The identified pathways are highly significant with the p -values ranging from 4.27 × 10–23 to 2.21 × 10–12.
← all excerpts
Comprehensive Kinase Activity Profiling Revealed the Kinase Activity Patterns Associated with the Effects of EGFR Tyrosine Kinase Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer Patients with Sensitizing EGFR Mutations.
1
—
—